Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa

Contraception

Volumn 81, Issue 6, 2010, Pages 547-551

  Laher, Fatima ^a   Todd, Catherine S ^b   Stibich, Mark A ^c   Phofa, Rebecca ^a   Behane, Xoliswa ^a   Mohapi, Lerato ^a   Martinson, Neil ^a,d   Gray, Glenda ^a  

^a Perinatal HIV Research Unit   (South Africa)

^b College of Physicians and Surgeons ^*  (United States)

^c Lacuna Projects   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; HIV; menstruation

Indexed keywords

ANTIRETROVIRUS AGENT; INJECTABLE CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTERVIEW; MENSTRUATION; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; SOUTH AFRICA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMENORRHEA; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; CULTURE; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; MIDDLE AGED; PATIENT PREFERENCE; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SOUTH AFRICA; TREATMENT REFUSAL; YOUNG ADULT;

EID: 77952322174     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.12.010     Document Type: Article

References (31)

1. Lima V.D., Hogg R.S., Harrigan P.R., et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 21 (2007) 685-692
2. Burr C.K., Fry R.S., Weber S., Armas-Kolostroubis L.N., and Lampe M.A. Integrating reproductive health into HIV care of women in the United States: it is time. AIDS 23 (2009) 1928-1930
3. Reynolds H.W., Janowitz B., Wilcher R., and Cates W. Contraception to prevent HIV-infected births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect 84 (2008) ii49-ii53
4. Quinn T.C., Wawer M.J., Sewankambo N., et al. Viral load and heterosexual transmission of HIV-1. Rakai project study group. New Engl J Med 342 (2000) 921-929
5. Myer L., Morroni C., and El-Sadr W. Reproductive decisions in HIV-infected individuals. Lancet 366 (2005) 698-700
6. World Health Organisation Task Force on Psychosocial Research in Family Planning. Special Programme of Research, Development and Research Training in Human Reproduction. A cross-cultural study of menstruation: implications for contraceptive development and use. Stud Fam Plann 12 (1981) 3-16
7. In: Berer M., Ravindran T.K.S., and Cottingham J. (Eds). Beyond acceptability: users perspective on contraception (1997), Reproductive Health Matters, London 1-124
8. Glasier A.F., Smith K.B., van der Spuy Z.M., et al. Amenorrhea associated with contraception - an international study on acceptability. Contraception 67 (2003) 1-8
9. Health Systems Trust. Health statistics - reproductive health. Accessed at:. http://www.hst.org.za/healthstats/index.php?indtype_id=003006002
10. Baumgartner J.N., Morroni C., Mlobeli R.D., et al. Timeliness of contraceptive reinjections in South Africa and its relation to unintentional discontinuation. Int Fam Plann Perspect 33 (2007) 66-74
11. Beksinska M.E., Rees H.V., and Smit J. Temporary discontinuation: a compliance issue in injectable users. Contraception 64 (2001) 309-313
12. Massad L.S., Evans C.T., Minkoff H., et al. Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Womens Health 15 (2006) 591-598
13. Greenblatt R.M., Hilton J., Palacio H., et al. Menstrual irregularity among HIV-seropositive women. Program and Abstracts of the HIV Infection in Women Conference; Feb 22-24, 1995; Washington, DC (1995) S51
14. Cohen M.H., Greenblatt R., Minkoff H., et al. Menstrual abnormalities in women with HIV infection. Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia (1996) Abstract Mo.B.540
15. Harlow S.D., Schuman P., Cohen M., et al. Effect of HIV infection on menstrual cycle length. JAIDS 24 (2000) 68-75
16. Ellerbrock T.V., Wright T.C., Bush T.J., Dole P., Brudney K., and Chiasson M.A. Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gyn 87 (1996) 1030-1034
17. Department of Health SA. National HIV and syphilis prevalence survey, South Africa 2006 (2007), Pretoria: Department of Health, South Africa. http://www.doh.gov.za Retrieved September 1, 2009, from
18. Chen J.L., Phillips K.A., Kanouse D.E., Collins R.L., and Miu A. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspec 33 (2001) 144-165
19. Hesse-Biber S.J.N., and Leavy P.L. The practice of qualitative research (2005), Sage Publications, Inc., Thousand Oaks (Calif) 213
20. Bernard H.R. Unstructured and semi-structured interviewing. In: Bernard H.R. (Ed). Research methods in anthropology: qualitative and quantitative approaches. 3rd ed. (2001), AltaMira Press, Walnut Creek (Calif) 208-236
21. Oesterheld J.R., Cozza K., and Sandson N.B. Oral contraceptives. Psychosomatics 49 (2008) 168-175
22. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction. Hormonal contraception and HIV: science and policy. Africa Regional Meeting. Nairobi 19-21 September 2005 (2005). http://www.who.int/reproductivehealth/topics/family_planning/nairobi_sta tement.pdf Accessed 08 September 2009 at
23. Konje J.C., and Ladipo O.A. Barriers to uptake and use of modern methods of contraception in developing countries. Int J Gynecol Obstet 65 (1999) 287-294
24. Laher F., Lephoto C., Forrest J., Cheyip M., and Mohapi L. The impact of parallel HAART and contraception service provision on elective terminations of pregnancy in Soweto, South Africa. Abstract #75. 4th South African AIDS Conference. 2009. Durban, South Africa (2009)
25. Halpern V., Grimes D.A., Lopez L., and Gallo M.F. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev 1 (2006) CD004317 10.1002/14651858.CD004317.pub2
26. Kalichman S.C., and Simbayi L.C. Sexual exposure to blood and increased risks for heterosexual HIV transmission in Cape Town, South Africa. Afr J Reprod Health 8 (2004) 55-58
27. Ramakrishnan U. Prevalence of micronutrient malnutrition worldwide. Nut Rev 60 suppl 5 (2002) S46-S52
28. Belperio P.S., and Rhew D.C. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 116 (2004) 27-43
29. Antelman G., Msamanga G.I., Spiegelman D., et al. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. J Nutr 130 (2000) 1950-1957
30. Laher F., Todd C.S., Stibich M.A., et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav 13 Suppl 1 (2009) 47-54
31. Andrade A., and Wildemeersch D. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS. Contraception 79 (2009) 134-138